Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

11.1K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
11.1K
Glaucoma: Overview01:25

Glaucoma: Overview

1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immuno-Proteomic Features Associated to Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.

Neurology·2026
Same author

Efficacy of Inebilizumab in N-MOmentum Trial Participants With or Without Prior Immunosuppressants.

Annals of clinical and translational neurology·2026
Same author

Video-EEG/polygraphy as a biomarker in the management of status epilepticus in anti-KELCH-like protein 11 encephalitis: Clinical and therapeutic implications.

Epileptic disorders : international epilepsy journal with videotape·2026
Same author

Identifying diagnostic biomarkers in functional motor disorders through multimodal behavioral, neurophysiological, and imaging assessment using explainable machine learning.

Journal of neurology·2026
Same author

Early corticosteroids predict visual whereas MRI lesion extent predicts retinal atrophy outcomes in MOG antibody-associated optic neuritis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Related Experiment Video

Updated: Apr 3, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

12.1K

Neuromyelitis Optica Spectrum Disorder.

Sara Mariotto, Romain Marignier

    Continuum (Minneapolis, Minn.)
    |April 2, 2026
    PubMed
    Summary
    This summary is machine-generated.

    Neuromyelitis Optica Spectrum Disorder (NMOSD) diagnosis and treatment are advancing with new biomarkers and targeted therapies. Early recognition of this rare autoimmune condition is key for better patient outcomes.

    More Related Videos

    Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
    12:23

    Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

    Published on: April 14, 2014

    14.7K
    Optic Nerve Sheath Point of Care Ultrasound: Image Acquisition
    06:09

    Optic Nerve Sheath Point of Care Ultrasound: Image Acquisition

    Published on: August 18, 2023

    3.4K

    Related Experiment Videos

    Last Updated: Apr 3, 2026

    Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
    09:29

    Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

    Published on: August 21, 2017

    12.1K
    Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
    12:23

    Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

    Published on: April 14, 2014

    14.7K
    Optic Nerve Sheath Point of Care Ultrasound: Image Acquisition
    06:09

    Optic Nerve Sheath Point of Care Ultrasound: Image Acquisition

    Published on: August 18, 2023

    3.4K

    Area of Science:

    • Neuroimmunology
    • Autoimmune diseases of the central nervous system

    Background:

    • Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare autoimmune condition affecting the central nervous system.
    • Discovery of aquaporin-4 antibodies has significantly advanced understanding of NMOSD pathogenesis.
    • Accurate diagnosis is critical for differentiating NMOSD from other neurological disorders and initiating timely treatment.

    Purpose of the Study:

    • To review the clinical features, diagnostic strategies, and treatment options for NMOSD.
    • To discuss rare NMOSD phenotypes, specific clinical contexts, and differential diagnoses.
    • To explore the role of novel biomarkers and ongoing revisions in diagnostic criteria for NMOSD.

    Main Methods:

    • Comprehensive literature review of clinical features, pathogenesis, and pathology of NMOSD.
    • Analysis of diagnostic approaches, including antibody testing and neuroimaging.
    • Evaluation of current and emerging therapeutic strategies, including targeted drugs.

    Main Results:

    • Identification of serum aquaporin-4 antibodies as a key diagnostic marker in most NMOSD patients.
    • Recent clinical trials have led to the approval of new targeted therapies for NMOSD.
    • Revised diagnostic criteria and ongoing research into biomarkers are improving disease recognition and management.

    Conclusions:

    • Early and accurate diagnosis of NMOSD is crucial for effective management and improved patient outcomes.
    • Advances in understanding pathogenesis, diagnostics, and targeted therapies are transforming NMOSD care.
    • Continued research into rare phenotypes, biomarkers, and novel treatments will further enhance the management of NMOSD.